Thomas A. Dix - Publications

1994- Pharmaceutical Sciences Medical University of South Carolina, Charleston, SC, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Lee JH, Wei ZZ, Cao W, Won S, Gu X, Winter M, Dix TA, Wei L, Yu SP. Regulation of Therapeutic Hypothermia on Inflammatory Cytokines, Microglia Polarization, Migration and Functional Recovery after Ischemic Stroke in Mice. Neurobiology of Disease. PMID 27659107 DOI: 10.1016/j.nbd.2016.09.013  0.48
2013 Hughes FM, Shaner BE, Brower JO, Woods RJ, Dix TA. Development of a Peptide-derived orally-active kappa-opioid receptor agonist targeting peripheral pain. The Open Medicinal Chemistry Journal. 7: 16-22. PMID 24222801 DOI: 10.2174/1874104501307010016  0.48
2012 Choi KE, Hall CL, Sun JM, Wei L, Mohamad O, Dix TA, Yu SP. A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2799-810. PMID 22459147 DOI: 10.1096/fj.11-201822  0.48
2010 Hughes FM, Shaner BE, May LA, Zotian L, Brower JO, Woods RJ, Cash M, Morrow D, Massa F, Mazella J, Dix TA. Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic. Journal of Medicinal Chemistry. 53: 4623-32. PMID 20481538 DOI: 10.1021/jm100092s  0.48
2009 Orwig KS, Lassetter MR, Hadden MK, Dix TA. Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy. Journal of Medicinal Chemistry. 52: 1803-13. PMID 19290594 DOI: 10.1021/jm801072v  1
2005 Hadden MK, Orwig KS, Kokko KP, Mazella J, Dix TA. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Neuropharmacology. 49: 1149-59. PMID 16095636 DOI: 10.1016/j.neuropharm.2005.06.010  1
2005 Hadden MK, Walle T, Dix TA. Cellular uptake of a radiolabelled analogue of neurotensin in the Caco-2 cell model. The Journal of Pharmacy and Pharmacology. 57: 327-33. PMID 15807988 DOI: 10.1211/0022357055560  1
2005 Kokko KP, Hadden MK, Price KL, Orwig KS, See RE, Dix TA. In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier. Neuropharmacology. 48: 417-25. PMID 15721174 DOI: 10.1016/j.neuropharm.2004.10.008  0.48
2005 May LA, Tourkina E, Hoffman SR, Dix TA. Detection and quantitation of curcumin in mouse lung cell cultures by matrix-assisted laser desorption ionization time of flight mass spectrometry. Analytical Biochemistry. 337: 62-9. PMID 15649376 DOI: 10.1016/j.ab.2004.10.037  0.48
2003 Kokko KP, Hadden MK, Orwig KS, Mazella J, Dix TA. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues. Journal of Medicinal Chemistry. 46: 4141-8. PMID 12954066 DOI: 10.1021/jm0300633  1
2002 Kokko KP, Dix TA. Monitoring neurotensin[8-13] degradation in human and rat serum utilizing matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Analytical Biochemistry. 308: 34-41. PMID 12234461  1
Show low-probability matches.